Vitamin-B 12 Status of Patients on Long-term Metformin Therapy

Authors:
  • GTG. H. Tomkin
    G. H. Tomkin
  • DHD. R. Hadden
    D. R. Hadden
  • JWJ. A. Weaver
    J. A. Weaver
  • DMD. A. D. Montgomery
    D. A. D. Montgomery

Abstract
Vitamin-B 12 malabsorption has been found in 21 (30%) of 71 diabetic patients taking long-term metformin therapy in addition to dietary management. The patients with evidence of B 12 malabsorption had significantly lower haemoglobin levels (and significantly higher serum folic acid levels) than those with normal B 12 absorption. Steatorrhoea was found in only one patient. Stopping metformin therapy resulted in reversion of B 12 absorption to normal in most patients examined. Four patients with B 12 malabsorption were found to have pathologically low serum B 12 levels. The causes and implications of these findings are discussed and it is concluded that all patients on long-term metformin therapy should have annual serum B 12 estimations.

This publication has 10 references indexed in Scilit: